Joshua Siegel

Joshua Siegel, a psychiatrist and systems neuroscientist at NYU, explores the fascinating realm of psychedelics and their impact on the brain. He discusses how fMRI technology unveils the intricate relationship between neural activity and blood flow. Siegel delves into the role of the serotonin 2A receptor and its significance in understanding psychedelics. The conversation also highlights the challenges of subjective experiences in clinical trials, revealing how individual expectations can shape treatment outcomes.